Microarray 2018 Global Market Growth, Opportunities And Analysis, Forecast To 2025

Mar 12, 2018

Market Analysis Research Report On “Global Microarray Market 2018 Industry Growth, Size, Trends, Share, Opportunities And Forecast To 2025” To Their Research Database.

Pune, India - March 12, 2018 /MarketersMedia/ —

Global Microarray Market

In this report, the global Microarray market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Global Microarray market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Thermo Fisher Scientific
Agilent Technologies
Merck
Illumina
Phalanx Biotech
Biometrix Technology
Perkin Elmer
Applied Microarrays
Arrayit
Takara Bio
BioGenex
LC Sciences
US Biomax
AXO Science
BioCat
Cepheid
GE Healthcare
InDevR
Qiagen

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3045481-global-microarray-market-research-report-2018

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Microarray in these regions, from 2013 to 2025 (forecast), covering
United States
EU
China
Japan
South Korea
Taiwan
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
DNA Microarray
Oligonucleotide Microarray
Protein Microarray
Tissue Microarray
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Life Science Research
Medical
Others

Table of Contents-Key Points Covered

Global Microarray Market Research Report 2018
1 Microarray Market Overview
1.1 Product Overview and Scope of Microarray
1.2 Microarray Segment by Type (Product Category)
1.2.1 Global Microarray Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Microarray Production Market Share by Type (Product Category) in 2017
1.2.3 DNA Microarray
1.2.4 Oligonucleotide Microarray
1.2.5 Protein Microarray
1.2.6 Tissue Microarray
1.3 Global Microarray Segment by Application
1.3.1 Microarray Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Life Science Research
1.3.3 Medical
1.3.4 Others
1.4 Global Microarray Market by Region (2013-2025)
1.4.1 Global Microarray Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 United States Status and Prospect (2013-2025)
1.4.3 EU Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 South Korea Status and Prospect (2013-2025)
1.4.7 Taiwan Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Microarray (2013-2025)
1.5.1 Global Microarray Revenue Status and Outlook (2013-2025)
1.5.2 Global Microarray Capacity, Production Status and Outlook (2013-2025)

………….

7 Global Microarray Manufacturers Profiles/Analysis
7.1 Thermo Fisher Scientific
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Microarray Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Thermo Fisher Scientific Microarray Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Agilent Technologies
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Microarray Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Agilent Technologies Microarray Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Merck
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Microarray Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Merck Microarray Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Illumina
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Microarray Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Illumina Microarray Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Phalanx Biotech
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Microarray Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Phalanx Biotech Microarray Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 Biometrix Technology
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Microarray Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Biometrix Technology Microarray Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Perkin Elmer
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Microarray Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Perkin Elmer Microarray Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Applied Microarrays
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Microarray Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Applied Microarrays Microarray Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Arrayit
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Microarray Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Arrayit Microarray Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Takara Bio
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Microarray Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Takara Bio Microarray Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 BioGenex
7.12 LC Sciences
7.13 US Biomax
7.14 AXO Science
7.15 BioCat
7.16 Cepheid
7.17 GE Healthcare
7.18 InDevR
7.19 Qiagen

Continued….

Complete Report Details @ https://www.wiseguyreports.com/reports/3045481-global-microarray-market-research-report-2018

NORAH TRENT

Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Contact Info:
Name: Norah Trent
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune
Phone: +1 (339) 368 6938 (US) +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/microarray-2018-global-market-growth-opportunities-and-analysis-forecast-to-2025/312385

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 312385

More News

Oct 12, 2026

HLB resubmits FDA application for liver cancer treatment

Korean drugmaker HLB has resubmitted its application for U.S. approval of a combination therapy for advanced liver cancer, renewing its push to bring the target treatment to market after addressing regulatory concerns raised earlier this year. The Korean biopharmaceutical company said Monday that its U.S. subsidiary, Elevar Therapeutics, and Chinese partner Hengrui Pharma submitted the application to the U.S. Food and Drug Administration (FDA) on Friday, seeking approval of rivoceranib in combination with camrelizumab as a first-line treatment for liver cancer. The resubmission follows an FDA complete response letter issued in July regarding an application Elevar filed in January, prompting the companies to work with regulators to address the agency’s concerns. HLB said inspections of the manufacturing facilities have recently been completed, allowing the companies to submit the application again. The filing is based on CARES-310, a global Phase 3 clinical trial involving patients with unresectable or metastatic liver cancer. In the trial’s final analysis, the combination treatment ac

Oct 12, 2026

Claude emerges as fastest-growing AI skill in Korean job postings

Korean employers are no longer just asking job candidates if they understand artificial intelligence (AI). Instead, they are requiring hands-on expertise with specific platforms — and Claude is leading the surge in recruitment demand. According to data released Monday by JobKorea, a human resources technology platform operated by Worksphere, recruitment postings mentioning generative AI tools like Claude, ChatGPT and Gemini jumped 170 percent in the third quarter compared to the same period last year. Among individual tools, Claude recorded the sharpest increase, with mentions climbing 770 percent, followed by Google’s Gemini at 500 percent, ChatGPT at 165 percent, Microsoft Copilot at 96 percent and Midjourney at 46 percent. Claude’s share of postings that named specific AI tools jumped from 17 percent last year to 55 percent this year, narrowing the gap with ChatGPT, whose share remained around 70 percent over the same period, according to JobKorea. Demand also grew for skills related to how AI is applied, with mentions of generative AI, prompt engineering, AI agents and vibe cod

Oct 12, 2026

Naver Map to offer voice guidance on Meta, Google, Samsung smart glasses

Naver Map, Korea’s most widely used online map service, will offer real-time, step-by-step voice navigation through artificial intelligence (AI)-powered smart glasses, becoming the first Korean map service to do so, its operator, Naver, said Monday. The feature is available first on Meta’s Ray-Ban Meta and Oakley Meta glasses, according to the internet portal operator. It will also support “intelligent eyewear” being jointly developed by Google and Samsung Electronics, which is set for release later this year. Users can receive voice directions to their destination without repeatedly checking their smartphone screens. The glasses also tell them which way to turn and whether stairs or escalators lie ahead. The service will first be available on Android phones, with iPhone support to follow. Naver Map has also introduced voice commands designed for the glasses. Users can ask questions such as “When will I arrive?” or “Find a convenience store nearby” while walking and get answers right away. On the Google-Samsung glasses, users will also be able to launch Naver Map and star

Oct 12, 2026

Gaon Cable to make nuclear power plant cables in US

Gaon Cable, an affiliate of LS Group, will build production lines for nuclear power plant cables at its U.S. plant in North Carolina, aiming to get ahead in a market expected to grow as the country expands nuclear power, the company said Monday. The Korean cable maker said its U.S. unit, LS Cable & System U.S.A., will install the equipment at its plant in Tarboro, North Carolina. The move is intended to build a local supply system ahead of the expected expansion of the U.S. market for large nuclear plants and small modular reactors (SMRs), smaller reactors that can be factory-built and installed in modules. The plant already produces overhead power lines for the U.S. grid. Adding nuclear cables will widen the range of products it makes locally. The company said the U.S. supply chain for nuclear plant equipment, including cables, remains thin because few new reactors have been built in the country for decades. Interest in new reactors has returned as electricity demand rises with the growing number of artificial intelligence data centers and as energy security becomes a priority. A single

Oct 12, 2026

SK Group opens 2-year AI academy with $2,200 monthly allowance

SK Group will launch a two-year, full-time, non-degree program for aspiring developers and early-career innovators focused on using artificial intelligence (AI) to solve real-world problems, the conglomerate said Monday. Participants in the initiative will receive a monthly stipend of 3 million won (approximately $2,200) to support their intensive training and practical application projects. The program, SK AIGEN, combines “AI” and “generation.” It is open to people aged 19 to 34 and will start in March 2027 with about 50 participants. Participants will receive the monthly stipend for two years, along with training, mentoring and workspace. The program does not guarantee a job at SK or grant a degree, and participants have no obligations after completing it. In the first year, participants will plan and carry out individual or team projects that use AI to tackle problems faced by individuals, companies and society. In the second year, they will gain hands-on experience in fields tied to their own career or project plans, with SK connecting them to mentors and experts. SK said this

Oct 12, 2026

Robots under attack

Food delivery robots have been kicked, beaten and tipped over. They have touched a nerve for many Americans who are concerned about AI technology.

Oct 12, 2026

China’s factories leaping straight into agentic AI and taking it global: Black Lake CEO

China’s manufacturing sector is leapfrogging straight into the era of agentic artificial intelligence and is now exporting that playbook to global supply chains, according to the CEO of Black Lake, a Chinese provider of cloud-based AI tools for factories. “Just as China skipped credit cards and jumped directly to mobile payments, many factories are skipping full traditional digitalisation and jumping directly to AI agents,” Zhou Yuxiang said in a recent interview with the South China Morning...

Oct 12, 2026

Apple said to be planning a second launch event on 27 October

Apple could unveil its first touchscreen OLED MacBook Pro, new M6-powered Macs, and an OLED iPad mini at the event.

Oct 12, 2026

China’s CXMT unveils ‘key progress’ on chip structure pursued by Samsung, SK Hynix

Chinese memory chip giant ChangXin Memory Technologies (CXMT) has reported “key progress” on a new cell architecture to boost memory density, an innovation that competitors such as Samsung Electronics and SK Hynix are also working on. CXMT planned to roll out a new server-memory product based on the structure by the end of 2026, president Cao Kanyu said at an industrial event in Shanghai over the weekend, according to a company statement. At the centre of the development is the “4F square”...

Apple reportedly cutting iPhone 18 Pro production due to soft demand

Oct 12, 2026

Microarray 2018 Global Market Growth, Opportunities And Analysis, Forecast To 2025

More News

HLB resubmits FDA application for liver cancer treatment

Claude emerges as fastest-growing AI skill in Korean job postings

Naver Map to offer voice guidance on Meta, Google, Samsung smart glasses

Gaon Cable to make nuclear power plant cables in US

SK Group opens 2-year AI academy with $2,200 monthly allowance

Robots under attack

China’s factories leaping straight into agentic AI and taking it global: Black Lake CEO

Apple said to be planning a second launch event on 27 October

China’s CXMT unveils ‘key progress’ on chip structure pursued by Samsung, SK Hynix

Apple reportedly cutting iPhone 18 Pro production due to soft demand

Honor X9e Pro 5G packs a power bank-sized battery with extreme drop resistance

Is your home ready for 45 connected devices? This family has over 120

Recommended

3 telecoms' Q3 profits to jump 84% to $1.04 bil.

Lawmakers slam Coupang for refusing to cooperate with antitrust probe

Lee orders stern response to alleged abuse of workers at car battery plant

Google Korea finally wins tax dispute against Korean tax office

Celltrion Q3 operating profit tops W500 bil. mark for 1st time

Less paperwork, AI-powered banking: KakaoBank joins race for foreign customers

Civic group files complaint against Kakao over alleged privacy law violations

AI pioneer sees Korea's role in developing world model

Air Premia captures 20% market share on LA route in 4th year of service

Hyosung Chemical brings high-performance plastics to Europe for EVs, robots